Open Access and Peer-reviewed Medical Journal
Home Journal Issues Guide for Authors Editorial Board Aims & Scope About Journal


Original Research Open Access


Changing of Hemoglobin A1c Affects Mean Platelet Volume in Type-2 Diabetes Mellitus

Huseyin Kurt, Davut Demirkiran.

Abstract
Background: Mean platelet volume (MPV) level is known to increase in diabetes mellitus (DM).
Objective: In this study, the first aim is to examine whether there is a correlation between MPV and hemoglobin A1c (HbA1c) and fasting plasma glucose (FPG). The second aim is to investigate whether a correlation exists between MPV and HbA1c and FPG changes after treatment
Method: In the study, we examined baseline and final HbA1c, MPV and FPGA values of 343 patients. Including the study group (SG) consisted of 169 patients with diabetes whose HbA1c levels decreased %1 and the control group involving 174 patients whose HbA1c levels did not change.
Results: Similar to CG, HbA1c level of SG decreased to 7.58, and MPV level reduced to 8.68. There existed a positive correlation between MPV and HbA1c levels (r=154; p<0.005). Additionally, positive correlation was found between MPV and HbA1c changes (r=216; p=0.005), and MPV and FPG changes (r=245; p=0.001) in SG. Moreover, there was a positive correlation between MPV and HbA1c changes (r=306; p<0.005), and MPV and FPG changes (r=306; p<0.005) in patients underwent insulin treatment.
Conclusion: The change in HbA1c level is similar to MPV level change. The effect of insulin therapy on MPV is significant.

Key words: Mean platelet volume, diabetes mellitus, hemoglobin A1c, fasting plasma glucose. 


 
ARTICLE TOOLS
Abstract
PDF Fulltext
Print this article Print this Article
How to cite this articleHow to cite this article
Export to
Export to
Related Records
 Articles by Huseyin Kurt
Articles by Davut Demirkiran
on Google
on Google Scholar
Article Statistics
 Viewed: 824
Downloaded: 365
Cited: 0


REFERENCES
1. Demirtas L, Degirmenci H, Akbas EM, Ozcicek A, Timuroglu A, Gurel A, et al. Association of hematological indicies with diabetes, impaired glucose regulation and microvascular complications of diabetes. International journal of clinical and experimental medicine. 2015;8(7):11420-7. [Pubmed]    [PMC Free Fulltext]   
2. American Diabetes A. Diagnosis and classification of diabetes mellitus. Diabetes care. 2007;30 Suppl 1:S42-7. [DOI via Crossref]    [Pubmed]   
3. Gerich JE. Type 2 diabetes mellitus is associated with multiple cardiometabolic risk factors. Clinical cornerstone. 2007;8(3):53-68. [DOI via Crossref]   
4. Fox CS, Coady S, Sorlie PD, D'Agostino RB, Sr., Pencina MJ, Vasan RS, et al. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation. 2007;115(12):1544-50. [DOI via Crossref]    [Pubmed]   
5. Danaei G, Lawes CM, Vander Hoorn S, Murray CJ, Ezzati M. Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet. 2006;368(9548):1651-9. [DOI via Crossref]   
6. Amin AA AW, Farrag AA. Impact of glycemic status on left ventricular systolic function in patients with acute coronary syndrome. Ulutas Med J. 2015;3(1):58-63. [DOI via Crossref]   
7.Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes care. 2007;30(1):162-72. [DOI via Crossref]    [Pubmed]   
8. Jeerakathil T, Johnson JA, Simpson SH, Majumdar SR. Short-term risk for stroke is doubled in persons with newly treated type 2 diabetes compared with persons without diabetes: a population-based cohort study. Stroke; a journal of cerebral circulation. 2007;38(6):1739-43. [DOI via Crossref]    [Pubmed]   
9. Shimodaira M, Niwa T, Nakajima K, Kobayashi M, Hanyu N, Nakayama T. Correlation between mean platelet volume and blood glucose levels after oral glucose loading in normoglycemic and prediabetic Japanese subjects. Journal of diabetes investigation. 2014;5(1):66-71. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
10.Colwell JA, Nesto RW. The platelet in diabetes: focus on prevention of ischemic events. Diabetes care. 2003;26(7):2181-8. [DOI via Crossref]   
11. Papanas N, Symeonidis G, Maltezos E, Mavridis G, Karavageli E, Vosnakidis T, et al. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets. 2004;15(8):475-8. [DOI via Crossref]    [Pubmed]   
12.Jindal S, Gupta S, Gupta R, Kakkar A, Singh HV, Gupta K, et al. Platelet indices in diabetes mellitus: indicators of diabetic microvascular complications. Hematology. 2011;16(2):86-9. [DOI via Crossref]    [Pubmed]   
13.Vinik AI, Erbas T, Park TS, Nolan R, Pittenger GL. Platelet dysfunction in type 2 diabetes. Diabetes care. 2001;24(8):1476-85. [DOI via Crossref]    [Pubmed]   
14.Herman WH, Fajans SS. Hemoglobin A1c for the diagnosis of diabetes: practical considerations. Polskie Archiwum Medycyny Wewnetrznej. 2010;120(1-2):37-40. [Pubmed]   
15. Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM, et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet. 2010;376(9739):419-30. [DOI via Crossref]   
16.American Diabetes A. Standards of medical care in diabetes--2014. Diabetes care. 2014;37 Suppl 1:S14-80. [DOI via Crossref]    [Pubmed]   
17.Authors/Task Force M, Ryden L, Grant PJ, Anker SD, Berne C, Cosentino F, et al. ESC Guidelines on diabetes, prediabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). European heart journal. 2013;34(39):3035-87. [DOI via Crossref]    [Pubmed]   
18.Anderson RT, Narayan KM, Feeney P, Goff D, Jr., Ali MK, Simmons DL, et al. Effect of intensive glycemic lowering on health-related quality of life in type 2 diabetes: ACCORD trial. Diabetes care. 2011;34(4):807-12. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
19.Genuth S, Eastman R, Kahn R, Klein R, Lachin J, Lebovitz H, et al. Implications of the United kingdom prospective diabetes study. Diabetes care. 2003;26 Suppl 1:S28-32. [DOI via Crossref]    [Pubmed]   
20.Winocour PD. Platelets, vascular disease, and diabetes mellitus. Canadian journal of physiology and pharmacology. 1994;72(3):295-303. [DOI via Crossref]    [Pubmed]   
21.Coban E, Kucuktag S, Basyigit S. Platelet activation in subjects with impaired glucose tolerance. Platelets. 2007;18(8):591-4. [DOI via Crossref]    [Pubmed]   
22.Coban E, Bostan F, Ozdogan M. The mean platelet volume in subjects with impaired fasting glucose. Platelets. 2006;17(1):67-9. [DOI via Crossref]    [Pubmed]   
23.Ulutas KT, Dokuyucu R, Sefil F, Yengil E, Sumbul AT, Rizaoglu H, et al. Evaluation of mean platelet volume in patients with type 2 diabetes mellitus and blood glucose regulation: a marker for atherosclerosis? International journal of clinical and experimental medicine. 2014;7(4):955-61. [Pubmed]    [PMC Free Fulltext]   
24.Demirtunc R, Duman D, Basar M, Bilgi M, Teomete M, Garip T. The relationship between glycemic control and platelet activity in type 2 diabetes mellitus. Journal of diabetes and its complications. 2009;23(2):89-94. [DOI via Crossref]    [Pubmed]   
25. Lippi G, Salvagno GL, Nouvenne A, Meschi T, Borghi L, Targher G. The mean platelet volume is significantly associated with higher glycated hemoglobin in a large population of unselected outpatients. Primary care diabetes. 2015;9(3):226-30. [DOI via Crossref]    [Pubmed]   
26. Kodiatte TA, Manikyam UK, Rao SB, Jagadish TM, Reddy M, Lingaiah HK, et al. Mean platelet volume in Type 2 diabetes mellitus. Journal of laboratory physicians. 2012;4(1):5-9. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
27. Shimodaira M, Niwa T, Nakajima K, Kobayashi M, Hanyu N, Nakayama T. Correlation between mean platelet volume and fasting plasma glucose levels in prediabetic and normoglycemic individuals. Cardiovascular diabetology. 2013;12:14. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
28.Hendra TJ, Oswald GA, Yudkin JS. Increased mean platelet volume after acute myocardial infarction relates to diabetes and to cardiac failure. Diabetes research and clinical practice. 1988;5(1):63-9. [DOI via Crossref]   
29. Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position 3 statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Circulation. 2009;119(2):351-7. [DOI via Crossref]    [Pubmed]   
30.Han JY, Choi DH, Choi SW, Kim BB, Ki YJ, Chung JW, et al. Stroke or coronary artery disease prediction from mean platelet volume in patients with type 2 diabetes mellitus. Platelets. 2013;24(5):401-6. [DOI via Crossref]    [Pubmed]   
31.Dolasik I, Sener SY, Celebi K, Aydin ZM, Korkmaz U, Canturk Z. The effect of metformin on mean platelet volume in diabetic patients. Platelets. 2013;24(2):118-21. [DOI via Crossref]    [Pubmed]   
32.Vernekar PV, Vaidya KA. Comparison of mean platelet volume in type 2 diabetics on insulin therapy and on oral hypoglycaemic agents. Journal of clinical and diagnostic research : JCDR. 2013;7(12):2839-40. [DOI via Crossref]   
33. Kramer CK, Zinman B, Retnakaran R. Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis. The lancet Diabetes & endocrinology. 2013;1(1):28-34. [DOI via Crossref]   

How to Cite this Article
Pubmed Style

Kurt H, Demirkiran D. Changing of Hemoglobin A1c Affects Mean Platelet Volume in Type-2 Diabetes Mellitus. Ulutas Med J. 2016; 2(1): 27-35. doi:10.5455/umj.20160211122820



Web Style

Kurt H, Demirkiran D. Changing of Hemoglobin A1c Affects Mean Platelet Volume in Type-2 Diabetes Mellitus. www.scopemed.org/?mno=215692 [Access: November 24, 2017]. doi:10.5455/umj.20160211122820



AMA (American Medical Association) Style

Kurt H, Demirkiran D. Changing of Hemoglobin A1c Affects Mean Platelet Volume in Type-2 Diabetes Mellitus. Ulutas Med J. 2016; 2(1): 27-35. doi:10.5455/umj.20160211122820



Vancouver/ICMJE Style

Kurt H, Demirkiran D. Changing of Hemoglobin A1c Affects Mean Platelet Volume in Type-2 Diabetes Mellitus. Ulutas Med J. (2016), [cited November 24, 2017]; 2(1): 27-35. doi:10.5455/umj.20160211122820



Harvard Style

Kurt, H. & Demirkiran, D. (2016) Changing of Hemoglobin A1c Affects Mean Platelet Volume in Type-2 Diabetes Mellitus. Ulutas Med J, 2 (1), 27-35. doi:10.5455/umj.20160211122820



Turabian Style

Kurt, Huseyin, and Davut Demirkiran. 2016. Changing of Hemoglobin A1c Affects Mean Platelet Volume in Type-2 Diabetes Mellitus. THE ULUTAS MEDICAL JOURNAL, 2 (1), 27-35. doi:10.5455/umj.20160211122820



Chicago Style

Kurt, Huseyin, and Davut Demirkiran. "Changing of Hemoglobin A1c Affects Mean Platelet Volume in Type-2 Diabetes Mellitus." THE ULUTAS MEDICAL JOURNAL 2 (2016), 27-35. doi:10.5455/umj.20160211122820



MLA (The Modern Language Association) Style

Kurt, Huseyin, and Davut Demirkiran. "Changing of Hemoglobin A1c Affects Mean Platelet Volume in Type-2 Diabetes Mellitus." THE ULUTAS MEDICAL JOURNAL 2.1 (2016), 27-35. Print. doi:10.5455/umj.20160211122820



APA (American Psychological Association) Style

Kurt, H. & Demirkiran, D. (2016) Changing of Hemoglobin A1c Affects Mean Platelet Volume in Type-2 Diabetes Mellitus. THE ULUTAS MEDICAL JOURNAL, 2 (1), 27-35. doi:10.5455/umj.20160211122820








AUTHOR LOGIN

REVIEWER LOGIN

Indexed
&
Abstracted


CrossRef

ScopeMed

Google Scholar

TUBITAK Dergipark

Index Scholar

Index Copernicus


ABOUT JOURNAL
POLICIES and STATEMENTS

The articles in Ulutas Medical Journal are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.